% Expired Patents = 13.3

EPO Patents = 1

Trademarks = 1

Forward Citations = 37

Loading Chart...

4 inventors (with patents filed for the assignee):

Taylor H Schreiber (15 out of 25 patents)

George Fromm (14 out of 16 patents)

Suresh De Silva (12 out of 14 patents)

4. Neal Schilling (4 out of 6 patents)

15 patents: Sort by Forward Citations

1. 11548930 - Intratumoral vaccination (2023-01-10),

2. 11547742 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2023-01-10),

3. 10780161 - Vector co-expressing vaccine and costimulatory molecules (2020-09-22),

4. 10758611 - Vector co-expressing vaccine and costimulatory molecules (2020-09-01),

5. 10660936 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-26),

6. 10653748 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-19),

7. 10646545 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-12),

8. 10543253 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-01-28),

9. 10525102 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-01-07),

10. 10493128 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-12-03),

11. 10449233 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-10-22),

12. 10188701 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-01-29),

13. 10183060 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-01-22),

14. 10086042 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2018-10-02),

15. 10046047 - Vector co-expressing vaccine and costimulatory molecules (2018-08-14),

Company Overview

Heat Biologics, Inc. is a biotechnology company based in Durham, North Carolina, specializing in the development of innovative immunotherapies for the treatment of cancer and infectious diseases. The company focuses on harnessing the power of the immune system to create therapies that can effectively target and destroy tumors. Heat Biologics is dedicated to advancing its proprietary technology platforms, which aim to enhance the body’s immune response, thereby improving patient outcomes in oncology and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#54 in Durham, NC

#466 in North Carolina

#21,068 in US

#39,959 in the World

Durham, NC, United States of America

Heat Biologics, Inc.

Forward Citations = 37

4 inventors:

Taylor H Schreiber (15 out of 25 patents)

George Fromm (14 out of 16 patents)

Suresh De Silva (12 out of 14 patents)

4. Neal Schilling (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Heat Biologics, Inc.. Retrieved from https://idiyas.com/company/heat-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]